This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

McNeil Products Ltd

Foundation Park, Roxborough Way, Maidenhead, Berks, SL6 3UG
Medical Information Direct Line: 01344 864042
Medical Information e-mail: crc@its.jnj.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 10/03/2008
SPC Anusol Ointment


Go to top of the page
1. Name of the medicinal product

Anusol Ointment


Go to top of the page
2. Qualitative and quantitative composition

Each 100g ointment contains:

Zinc Oxide 10.75 g

Bismuth Subgallate 2.25 g

Balsam Peru 1.875 g

Bismuth Oxide 0.875 g


Go to top of the page
3. Pharmaceutical form

A light buff coloured ointment.


Go to top of the page
4. Clinical particulars

Go to top of the page
4.1 Therapeutic indications

Symptomatic relief of uncomplicated internal and external haemorrhoids, pruritus ani, proctitis and fissures. Also indicated post operatively in ano-rectal surgical procedures and after incision of thrombosed or sclerosed ano-rectal veins.

Anusol Ointment provides antiseptic, astringent and emollient properties which help to relieve discomfort associated with minor ano-rectal conditions.


Go to top of the page
4.2 Posology and method of administration

Topical.

Adults and Elderly (over 65 years): Apply to the affected area at night, in the morning and after each evacuation until the condition is controlled. Thoroughly cleanse the affected area, dry and apply ointment. Anusol Ointment should be applied on a gauze dressing. For internal conditions use rectal nozzle provided. Remove the nozzle cap. Clean the nozzle after each use. Not to be taken orally.

Children: Not recommended


Go to top of the page
4.3 Contraindications

Known hypersensitivity to any of the constituents.


Go to top of the page
4.4 Special warnings and precautions for use

None known.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6. Pregnancy and lactation

Whilst formal studies on the effect of this product during pregnancy have not been conducted, there is no epidemiological evidence of adverse effects either to the pregnant mother or foetus.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Rarely, sensitivity reactions. Patients may occasionally experience transient burning on application, especially if the anoderm is not intact.


Go to top of the page
4.9 Overdose

Treatment of a large acute overdose should include gastric lavage, purgation with magnesium sulphate and complete bed rest. If necessary, apply oxygen and give general supportive measures.


Go to top of the page
5. Pharmacological properties

Go to top of the page
5.1 Pharmacodynamic properties

Anusol Ointment provides antiseptic, astringent and emollient properties which help to relieve discomfort associated with minor ano-rectal conditions.

Bismuth Oxide is weakly astringent with supposed antiseptic properties and has a protective action on mucous membranes and raw surfaces.

Zinc Oxide is an astringent and mild antiseptic and probably owes its actions to the ability of the zinc ion to precipitate protein but other mechanisms may be involved. Zinc Oxide is also used to absorb skin moisture and decrease friction and discourage growth of certain bacteria.

Balsam Peru has a very mild antiseptic action by virtue of its content of cinnamic and benzoic acids. It is believed to promote the growth of epithelial cells.


Go to top of the page
5.2 Pharmacokinetic properties

The active ingredients exert their therapeutic effect without being absorbed into the systemic circulation. These observations are supported by evidence from various studies and reviews.


Go to top of the page
5.3 Preclinical safety data

The active ingredients of Anusol are well known constituents of medicinal products and their safety profile is well documented.


Go to top of the page
6. Pharmaceutical particulars

Go to top of the page
6.1 List of excipients

Anusol Ointment contains the following excipients:-

Magnesium stearate

Cocoa butter

Lanolin anhydrous

Castor oil

Kaolin light

Petroleum Jelly White


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

Not less than 3 years when stored in the original packing.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25° C.


Go to top of the page
6.5 Nature and contents of container

Externally printed and internally lacquered 25 g aluminium tube with plastic cap. A plastic nozzle with cap is also provided for internal application.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
Administrative data

Go to top of the page
7. Marketing authorisation holder

McNeil Products Limited

Foundation Park

Roxborough Way

Maidenhead

Berkshire

SL6 3UG

United Kingdom


Go to top of the page
8. Marketing authorisation number(s)

15513/0042


Go to top of the page
9. Date of first authorisation/renewal of the authorisation

14 March 1997


Go to top of the page
10. Date of revision of the text

25 February 2008



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/7162/SPC/


Active Ingredients/Generics